Elaboration of Charged Poly(Lactic-co-Glycolic Acid) Microparticles for Effective Release of Tranexamic Acid

被引:5
作者
Huang, Ming-Hsi [1 ]
Huang, Shun-Ying [2 ]
Chen, Yi-Xuan [2 ]
Chen, Cheng-You [3 ]
Lin, Yung-Sheng [2 ,3 ]
机构
[1] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli 35053, Taiwan
[2] Natl United Univ, Dept Chem Engn, Miaoli 36063, Taiwan
[3] Natl United Univ, PhD Program Mat & Chem Engn, Miaoli 36063, Taiwan
关键词
poly(lactic-co-glycolic acid); cetyltrimethylammonium bromide; tranexamic acid; controlled release; charge effect; DRUG-DELIVERY; PLGA NANOPARTICLES; FORMULATION;
D O I
10.3390/polym12040808
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
In this study, tranexamic acid (TA) was used as a model compound to study the charge effect on the physicochemical properties of poly(lactic-co-glycolic acid) (PLGA) microparticles (MPs). Charged PLGA MPs were elaborated by the incorporation of a quaternary ammonium, cetyltrimethylammonium bromide (CTAB), during the double emulsion solvent evaporation process. Three TA-CTAB-carrying modes of PLGA MPs were designed in the CTAB-free (TA-MP), adsorption (TA-CTAB(AD)), or encapsulation (TA-CTAB(EN)) form. The obtained MPs were characterized by morphology and TA-MP affinity. The experiment revealed that the three prepared MPs were spherical and smooth, with pores on their surfaces. TA-CTAB(AD) had a relatively narrow size distribution, compared with that of TA-MP and TA-CTAB(EN). The particle sizes of TA-MP, TA-CTAB(EN), TA-CTAB(AD) were measured as 59 +/- 17, 54 +/- 20, and 19 +/- 8 mu m, respectively. The zeta potential of the three MPs was found to be in the order: TA-CTAB(AD) > TA-CTAB(EN) > TA-MP. Differential scanning calorimetry (DSC) indicated that the manufacturing process had no influence on the glass transition temperature of the MPs, which was close to 48 degrees C. Thermogravimetric analysis illustrated that the presence of CTAB slightly changed the thermal stability of PLGA MPs. In vitro release showed that TA-CTAB(AD) exhibited faster TA release than TA-MP and TA-CTAB(EN) in a basic environment (pH of 13), probably because of electrostatic attraction. At pH = 1, the release of TA from TA-CTAB(EN) was faster than those from TA-MP and TA-CTAB(AD), probably because of electrostatic repulsion. However, the effect of electrostatic interaction was not significant at pH = 7.4.
引用
收藏
页数:10
相关论文
共 31 条
[1]   PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect [J].
Acharya, Sarbari ;
Sahoo, Sanjeeb K. .
ADVANCED DRUG DELIVERY REVIEWS, 2011, 63 (03) :170-183
[2]   Microfluidic Based Fabrication and Characterization of Highly Porous Polymeric Microspheres [J].
Amoyav, Benzion ;
Benny, Ofra .
POLYMERS, 2019, 11 (03)
[3]   MEMBRANE OSMOMETRY OF AQUEOUS MICELLAR SOLUTIONS OF PURE NONIONIC AND IONIC SURFACTANTS [J].
ATTWOOD, D ;
ELWORTHY, PH ;
KAYNE, SB .
JOURNAL OF PHYSICAL CHEMISTRY, 1970, 74 (19) :3529-&
[4]   Topical 5% tranexamic acid for the treatment of melasma in Asians: A double-blind randomized controlled clinical trial [J].
Ayuthaya, Pinyapat Kanechorn Na ;
Niumphradit, Nucha ;
Manosroi, Aranya ;
Nakakes, Artit .
JOURNAL OF COSMETIC AND LASER THERAPY, 2012, 14 (03) :150-154
[5]   Efficient and prolonged antibacterial activity from porous PLGA microparticles and their application in food preservation [J].
Biswal, Agni Kumar ;
Hariprasad, P. ;
Saha, Sampa .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2020, 108
[6]   High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization [J].
Cun, Dongmei ;
Jensen, Ditte Krohn ;
Maltesen, Morten Jonas ;
Bunker, Matthew ;
Whiteside, Paul ;
Scurr, David ;
Foged, Camilla ;
Nielsen, Hanne Morck .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 77 (01) :26-35
[7]   PLGA-based nanoparticles: An overview of biomedical applications [J].
Danhier, Fabienne ;
Ansorena, Eduardo ;
Silva, Joana M. ;
Coco, Regis ;
Le Breton, Aude ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :505-522
[8]   Spectrophotometric and spectrofluorimetric methods for the determination of tranexamic acid in pharmaceutical formulation [J].
El-Aroud, Khalifa Abulghasem ;
Abushoffa, Adel Mohamed ;
Abdellatef, Hisham Ezzat .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2007, 55 (03) :364-367
[9]   USE OF AN ANTI-FIBRINOLYTIC AGENT (TRANEXAMIC ACID) IN MANAGEMENT OF RUPTURED INTRACRANIAL ANEURYSMS [J].
GIBBS, JR ;
CORKILL, AGL .
POSTGRADUATE MEDICAL JOURNAL, 1971, 47 (546) :199-&
[10]   A validated assay for the quantitative analysis of tranexamic acid in human serum by liquid chromatography coupled with electrospray ionization mass spectrometry [J].
Grassin Delyle, Stanislas ;
Abe, Emuri ;
Batisse, Anne ;
Tremey, Benjamin ;
Fischler, Marc ;
Devillier, Philippe ;
Alvarez, Jean Claude .
CLINICA CHIMICA ACTA, 2010, 411 (5-6) :438-443